Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 54 of 68 of this archive, newest first.
The route did not close because of a rule about peptides.
Deamidation, oxidation, aggregation and hydrolysis account for nearly all of what happens to a peptide over time. Each has a characteristic residue, a characteristic…
The dose-response curve in this class flattens near its top. That has direct consequences for whether the final rung is worth climbing.
Reported from the analysis, not from a warning notice.
Follow the resin, not the catalogue.
The evidence base is thin and the document says so, which is to its credit.
Reported from the sessions, and from the two hours afterwards.
The regain trajectories, arm by arm, with the estimands named.
What the labels permit, what clinicians do, and the size of the gap between them.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The route did not close because of a rule about peptides.
Reported from the sessions, and from the two hours afterwards.
Selectivity, potency and efficacy are three different measurements. The trade routinely reports none of them.
The sequence predicts the failure mode. A methionine predicts oxidation; an asparagine followed by a glycine predicts deamidation; a cysteine predicts disulphide scrambling.
The evidence base is thin and the document says so, which is to its credit.
The document is four pages. Three of them are about dates.
A proper account of an operation that existed, and of what closing it cost.
Efficacy was never the question in this appraisal. Duration of treatment was.
A tour of the source literatures, with an assessment of how far each legitimately reaches.
What would be needed to catch each of these, and what it would cost.
What scintigraphy and breath-test studies established about emptying rate, and what they did not.
The route did not close because of a rule about peptides.
Follow the resin, not the catalogue.
The result is unremarkable. What the report states alongside it is not.
A proper account of an operation that existed, and of what closing it cost.
The Journal does not treat a badge as evidence and states so wherever it reports one.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
The observation that closes a facility is rarely the dramatic one.
We describe each pathway in enough chemical detail to explain why it is invisible to the method the trade uses, because that is the part which has practical consequences.